Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KYAT3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | KIF26A | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | GPR173 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | COPS7A | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | HIST1H2BD | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | AC104581.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | MDH1B | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | CSRNP3 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | ZNF672 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |